Bangkok, Thailand, 9 July 2026– MGI Tech Co., Ltd. (“MGI”), a company dedicated to developing core tools and technologies that drive innovation in life sciences, is showcasing its latest innovations at World Health Expo (“WHX”) Bangkok 2026 from July 8 to 10. The exhibition highlights advanced tools across three primary business segments: SEQ ALL, GLI, and Multi-omics. Featured innovations include the high-efficiency PrepALL liquid handling system and the newly introduced Fluorometers series for fluorescence-based quantitative analysis.
PrepALL with Library Preparation: Automated Efficiency for High-Throughput Sequencing
The standard PrepALL liquid handling system features eight independent channels within a compact, space-saving design. It delivers high-precision pipetting performance alongside an intuitive user interface. Designed to simplify complex laboratory workflows, PrepALL offers enterprise-grade performance without the high capital costs of traditional automation. This makes it an ideal solution for laboratories transitioning to automation or scaling up existing research capacity.
At the event, MGI announce the expansion of the system’s capabilities by integrating an automated library preparation workflow into the latest PrepALL version. This upgrade enables hands-free, streamlined workflows for high-throughput sequencing applications. Empirical validation data demonstrates that PrepALL delivers high sensitivity, exceptional accuracy, and stable library preparation success rates. The system currently supports a diverse range of molecular biology applications, including high-throughput long- and short-read sequencing library preparation, WES library preparation, plasmid preparation and molecular cloning.
Fluorometers Series: Precision Quantification Across Molecular Biology Workflows
Accurate sample quantification is vital for successful outcomes in both high-throughput sequencing and general molecular biology experiments. To solve common quantification challenges, the MGI Fluorometer series combines precision, efficiency, and ease of use for modern laboratories. Utilizing advanced fluorometric detection technology, the series offers key technical advantages. The series offers key technical advantages:
- Ultra-High Sensitivity: Integrated with a high-sensitivity silicon photomultiplier tube (SiPM) detector, the Fluorometer series can detect low-concentration nucleic acids and proteins with unparalleled precision—down to 0.01 ng/μL for dsDNA.
- Speed & Efficiency: The Fluorometer series can achieve rapid detection in ≤5 seconds per sample with minimal volume requirements (1–20 μL).
- Exceptional Specificity: Fluorescence-based assays isolate and target dsDNA, ssDNA, RNA, and proteins individually. This ensures results remain unaffected by common contaminants like free nucleotides, proteins, or salts.
MGI invites researchers, laboratory managers, and biotechnology professionals to explore its extended genomics portfolio at WHX Bangkok 2026.
Attendees can view live product demonstrations at Hall 7, Booth #L02.
